Viridian Therapeutics Inc... (VRDN)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue 314.00K 1.77M 2.96M 1.05M 4.46M 8.39M 4.00M 3.34M 2.54M 4.32M 4.32M 4.41M
Cost of Revenue 1.32M 755.00K 620.00K 28.30M 32.79M 30.42M 19.62M 2.55M 2.47M 3.24M 2.50M 3.04M
Gross Profit -1.01M 1.02M 2.34M -27.25M -28.33M -22.04M -15.62M 789.00K 66.00K 1.08M 1.82M 1.36M
Operating Income -254.45M -134.30M -79.73M -110.38M -41.98M -33.08M -26.53M -12.51M -11.19M -6.87M -196.21K -4.03M
Interest Income 18.56M 4.92M 318.00K 173.00K 941.00K 1.25M 403.00K n/a n/a n/a n/a n/a
Pretax Income -237.73M -129.87M -79.41M -110.72M -41.87M -32.70M -26.51M -12.67M -11.33M -7.89M -2.16M -5.62M
Net Income -237.73M -125.44M -79.42M -110.98M -42.42M -32.70M -26.51M -12.67M -11.33M -7.89M -2.16M -7.21M
Selling & General & Admin 95.00M 35.18M 25.80M 13.27M 11.65M 11.05M 10.91M 9.57M 10.25M 7.75M 2.17M 4.23M
Research & Development 159.76M 100.89M 56.89M 28.30M 34.79M 30.42M 19.62M 888.00K 1.00M 293.00K 96.85K 225.38K
Other Expenses n/a n/a n/a 69.86M n/a n/a n/a 2.83M n/a n/a n/a n/a
Operating Expenses 254.76M 136.08M 82.69M 41.57M 46.44M 41.47M 30.54M 10.46M 11.25M 8.04M 2.26M 4.46M
Interest Expense 1.85M 486.00K 3.00K 508.00K 835.00K 873.00K 383.00K 95.00K 141.00K 1.02M 1.96M 1.59M
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a 1.67M 2.56M 717.00K 378.77K 1.33M
Cost & Expenses 254.76M 136.08M 82.69M 41.57M 46.44M 41.47M 30.54M 13.01M 13.72M 11.29M 4.76M 7.50M
Income Tax n/a -4.43M 3.00K 269.00K 547.00K 1.25M 95.00K 95.00K n/a 1.02M 1.96M 3.18M
Shares Outstanding (Basic) 44.76M 32.09M 11.92M 3.56M 2.09M 1.97M 1.28M 721.41K 539.45K 150.39K 188.12K 186.09K
Shares Outstanding (Diluted) 44.76M 32.09M 11.92M 3.56M 2.09M 1.97M 1.28M 721.41K 539.46K 150.39K 188.12K 186.09K
EPS (Basic) -5.31 -3.91 -6.66 -31.2 -20.31 -16.57 -20.66 -17.57 -21 -52.46 -11.48 -38.75
EPS (Diluted) -5.31 -3.91 -6.66 -31.2 -20.31 -16.57 -20.66 -17.57 -21 -52.46 -11.48 -38.75
EBITDA -234.56M -128.63M -78.79M -109.67M -40.75M -31.55M -25.82M -12.51M -11.00M -6.72M -47.90K -3.88M
Depreciation & Amortization 522.00K 755.00K 620.00K 539.00K 288.00K 281.00K 308.00K 341.00K 184.00K 144.00K 148.31K 144.29K